Skip to main content
. 2018 Nov 7;8:16475. doi: 10.1038/s41598-018-34830-9

Figure 5.

Figure 5

Effects of BMS-345541 in cultured human articular chondrocytes. (a) mRNA levels of MMP13, ADAMTS5, and COL2A1 in human primary articular chondrocytes treated with different concentrations of BMS-345541 with or without 10 ng/ml IL-1β. BMS-345541 and IL-1β were added simultaneously, and the cells were cultured for an additional 24 h. The cells obtained from the three individuals showed similar responses, and a representative result is shown. Symbols represent individual points; long and short bars show the mean and SD of three wells per group, respectively. *P < 0.01, **P < 0.001, ***P < 0.0001 vs IL-1β+/BMS-345541− by the Kruskal–Wallis test and Dunn’s post hoc test for unequal variance. (b) Immunoblot analyses of human primary articular chondrocytes treated simultaneously with different concentrations of BMS-345541 with or without 10 ng/ml IL-1β. (c) Luciferase activities in human articular chondrocytes transfected with the NF-κB reporter vector. BMS-345541 was added 24 h after transfection, and the cells were cultured for an additional 24 h. Symbols represent individual points; long and short bars show the mean and SD of five wells per group, respectively. *P < 0.0001 vs IL-1β+/BMS-345541− by the Kruskal–Wallis test and Dunn’s post hoc test for unequal variance.